The patatin-like lipase family in Gallus gallus
© Saarela et al; licensee BioMed Central Ltd. 2008
Received: 04 March 2008
Accepted: 12 June 2008
Published: 12 June 2008
In oviparous species, genes encoding proteins with functions in lipid remodeling, such as specialized lipases, may have evolved to facilitate the assembly and utilization of yolk lipids by the embryo. The mammalian gene family of patatin-like phospholipases (PNPLAs) has received significant attention, but studies in other vertebrates are lacking; thus, we have begun investigations of PNPLA genes in the chicken (Gallus gallus).
We scanned the draft chicken genome using human PNPLA sequences, and performed PCR to amplify and sequence orthologous cDNAs. Full-length cDNA sequences of galline PNPLA2/ATGL, PNPLA4, -7, -8, -9, and the activator protein CGI-58, as well as partial cDNA sequences of avian PNPLA1, -3, and -6 were obtained. The high degree of sequence identities (~50 to 80%) between the avian and human orthologs suggests conservation of important enzymatic functions. Quantitation by qPCR of the transcript levels of PNPLA s and CGI-58 in 21 tissues indicates that expression patterns and levels diverge greatly between species. A particularly interesting tissue in which certain PNPLAs may contribute to physiological specialization is the extraembryonic yolk sac.
Knowledge about the exact in-vivo functions of PNPLAs in any system is still sparse. Thus, studies about the temporal expression patterns and functions of the enzymes identified here, and of other already known extracellular lipases and co-factors, in the yolk sac and embryonic tissues during embryogenesis are called for. Based on the information obtained, further studies are anticipated to provide important insights of the roles of PNPLAs in the yolk sac and embryo development.
In egg-laying species, the oocyte's yolk is the major source of nutrients and regulatory factors for the developing embryo. The accumulation of yolk is predominantly the result of massive transport of lipids and proteins from the liver to oocytes situated within ovarian follicles . In mature hens of the domesticated chicken (Gallus gallus), fully-grown oocytes contain up to 5 g triacylglycerols (TG) and 240 mg cholesterol, and ovulate every 25 h. In parallel to this oocyte-targeted flow, lipid homeostasis of somatic tissues including the follicular cell layers is maintained. Subsequent to fertilization of the oocyte, normal embryo growth likewise depends on efficient nutrient transfer, i.e., mainly of lipid components, from the yolk into the embryonic circulation. These mobilization processes are maintained through concerted regulation of lipoprotein metabolism involving genes for lipases, lipid transfer proteins, lipoprotein receptors, and others. Thus, the laying hen is a prime model for delineating molecular mechanisms underlying both unidirectional (hepato-oocyte-embryo) mass lipid transfer and fine-tuned regulation of systemic lipid metabolism. Moreover, the known components of this dichotomous regulatory system are highly similar to those in mammals including man, despite the specific tasks they perform . Finally, the laying hen's lipid metabolism is a remarkable paradigm for hormonal control, as estrogen directly regulates not only the hepatic expression of genes for yolk precursor synthesis (e.g., vitellogenin and very low density lipoproteins, VLDL) [3, 4], but likely is also involved in the modulation of lipolytic activities and lipid transfer processes important in deposition of yolk into oocytes and subsequent embryonic yolk utilization . Estrogen also induces a unique apolipoprotein residing on VLDL particles, i.e., apoVLDL-II, which inhibits VLDL-lipolysis by lipoprotein lipase (LPL) in the circulation, thereby assuring efficient transport of TG into the oocyte for subsequent use by the growing embryo . Thus, to mediate the mobilization of lipids from yolk, lipolytic enzymes resistant to apoVLDL-II must exist which allow the developing embryo to efficiently access the lipid moiety of yolk lipoproteins.
Yolk mobilization to the embryo proper is mediated by the endodermal endothelial cells of the extraembryonic yolk sac enclosing the yolk during embryogenesis. These cells take up VLDL from the adjacent oocytic yolk via receptor-mediated endocytosis, degrade the particles in lysosomes, and de novo synthesize and secrete lipoproteins into the embryonic circulation. The yolk sac-derived VLDL particles subsequently serve as a source of lipid components and of important nutrients in embryo development . Thus, we can define four crucial steps for the ultimate utilization of lipids by the chicken embryo. These steps are, in temporal order: i) massive hormonal induction of yolk precursor synthesis in the maternal liver; ii) oocyte-directed receptor-mediated transport of yolk precursors and their limited proteolysis to form yolk; iii) mobilization of yolk components, mainly lipoproteins, via the yolk sac tissue into the embryonic circulation; and iv) finally, lipid utilization by the tissues of the developing embryo.
The flux of lipid components derived from lipid-carrying macromolecules, from the adult to the yolk, as well as from yolk to the embryo, presumably requires a large number of proteins including a set of lipid hydrolases and regulatory proteins. However, with the exception of the identification of LPL [8, 9] and the delineation of circulating apoVLDL-II as inhibitor of LPL , to date very little is known about other lipolytic enzymes of the chicken, their genes, expression patterns, modulation and regulation, let alone their functional properties in the above described processes. In man, several patatin-like lipases were identified [10, 11], but their physiological roles, with the exception of adiposome TG-lipase (ATGL) [12, 13], remain to be elucidated. The patatin-like phospholipases (PNPLAs) contain a patatin domain with lipid acyl hydrolase activity that has been described as nonspecific. Patatin was first identified in potato tubers , and subsequently patatin-like phospholipases have been found in pro- and eukaryotes . The patatin domain contains an active site with a serine-aspartate catalytic dyad and an oxyanion hole that stabilizes the enzyme-substrate transition state . The patatin domain shares a conserved core module with mammalian lipases, where the nucleophilic serine is located in a tight turn between a β-sheet and an α-helix in a well conserved β-β-α-β core structure  which is also present in, e.g., human cytosolic phospholipase A2 .
This report provides the first identification, sequence information, and expression profiling of PNPLAs and the associated activator protein (CGI-58) in the chicken. We propose that these newly identified proteins function in processes controlling the distribution and utilization of lipid components within the hepato-oocyte-embryo axis of the chicken.
Identification and sequencing of novel chicken genes
To identify novel chicken patatin-like lipases, and the PNPLA2/ATGL-activating protein CGI-58, the draft chicken genomic database was queried using sequences from the human orthologs. The nomenclature of the human PNPLAs as suggested by Wilson et al.  is adopted throughout this text. PCR was performed to amplify the identified sequences using chicken adipose tissue cDNA as template. The resulting DNA fragments were cloned and sequenced. By this approach we obtained the full-length cDNA clones from the chicken genes corresponding to PNPLA2/ATGL, PNPLA4, PNPLA8, PNPLA9, PNPLA7, and CGI-58. In addition, we were able to clone partial cDNAs from PNPLA1, PNPLA3, and PNPLA6. The mRNA sequences of the putative chicken PNPLAs and CGI-58 were deposited in GenBank under accession numbers EU419873 (CGI-58), EU419874 (PNPLA2/ATGL), EU419875 (PNPLA3), EU419876 (PNPLA1), EU419877 (PNPLA4), EU419878 (PNPLA8), EU419879 (PNPLA9), EU419880 (PNPLA6), and EU419881 (PNPLA7).
Summary of key features of the patatin-like lipases and CGI-58 from chicken (Gg) and man (Hs).
Chr. location Gg/Hs
Size cDNA (bp) Gg/Hs
Size protein (aa) Gg/Hs
Patatin domain (aa) Gg/Hs
Identity (%) Gg vs. Hs
Accession number mRNA Gg
Accession number mRNA Hs
PNPLA2 ATGL iPLA2ζ desnutrin TTS-2
TG hydrolysis , transacylase 
PNPLA3 adiponutrin iPLA2ε
Lipase , transacylase 
PNPLA4 iPLA2η GS2
Lipase , transacylase 
Lysophospholipid hydrolysis , cell signaling 
PNPLA7 NTE-related esterase NRE
Esterase , Lysophospho-lipase 
Potential lipase 
PNPLA9 PLA2G6 iPLA2β
Activation of PNPLA2/ATGL 
PNPLA2/ATGL (also called desnutrin, iPLA2ζ, or TTS-2) is the key enzyme for the generation of diglycerides from TG [12, 13], and is functionally conserved from yeast to man [20, 21]. The enzyme is activated by the protein termed "comparative gene identification 58" (CGI-58, also known as ABHD5) . Deficiency of CGI-58 in man leads to a rare autosomal recessive disease of lipid metabolism, Chanarin-Dorfman syndrome (also called neutral lipid storage disease with ichthyosis; OMIM 275630), characterized by the presence of abnormally large amounts of TG-rich lipid droplets in many tissues [23, 24]. Here, we determined that the chicken CGI-58 protein is 79% identical to the human ortholog, the amino acid residues critical for the activation of PNPLA2/ATGL , and the putative lipase motif are fully conserved.
PNPLA3 (also known as adiponutrin or iPLA2ε) was shown to behave differently from PNPLA2/ATGL with respect to regulation and cellular localization [11, 25, 26]. PNPLA3 is strongly suppressed upon fasting, but PNPLA2/ATGL expression is increased. Intracellularly, PNPLA3 localizes to membranes, whereas PNPLA2/ATGL is cytosolic.
The human PNPLA family member PNPLA1 has not been fully cloned nor its function studied [11, 19]. We were unable to obtain the full-length clone of chicken PNPLA1 cDNA, and PCR with several primer pairs was unsuccessful; however, sequence encoding the patatin domain could be obtained. Finally, we could not find any ESTs relevant to PNPLA1 in the chicken EST-databases [27, 28]. Equally, we could not obtain evidence for the existence of PNPLA5 (also termed GS2-like) in the chicken, since the chicken sequence databases available contain no DNA or protein sequence similar to the human or other known orthologs. Immunoprecipitated human PNPLA5 showed lipase activity, and when overexpressed it functioned to decrease intracellular TGs .
PNPLA4, also called gene sequence 2 (GS2) or iPLA2η, was demonstrated to be expressed in essentially all human tissues and to lipolyze TGs . To date, a murine PNPLA4 ortholog has not been reported.
Of the two reportedly unique members of the human patatin-like family , PNPLA8 (iPLA2γ) is ubiquitously expressed at moderate levels and reported to be transiently upregulated during early differentiation of human adipocytes. The other lipase in this group, PNPLA9, is predominantly expressed in adipose tissue and brain, and is upregulated late during adipocyte differentiation . Endogenous PNPLA9 purified from Chinese hamster ovary cells hydrolyzes dipalmitoyl phosphatidylcholine, and the ankyrin repeats are required for enzyme activity .
PNPLA6 (also known as neuropathy target esterase, NTE) is expressed, e.g., in human blood lymphocytes  and murine brain  and plays a role in membrane lipid homeostasis [32, 33]. PNPLA6 was suggested to be involved in a cell-signaling pathway controlling interactions between neurons and glial cells in the developing nervous system . Human [34, 35], murine [36, 37], and galline [34, 38] PNPLA6 were thoroughly studied in relation to their organophosphate-induced inactivation and neuronal degeneration. Finally, rat PNPLA7 (also known as NTE-related esterase or NRE), is highly expressed in prostate, pancreas, and adipose tissue , and insulin down-regulates the mouse enzyme, which predominates in testes, skeletal and cardiac muscle, and adipose tissue . The primary sequences of PNPLA6 and -7 have a high degree of identity; their similar features indicate conserved functions. PNPLA7 was suggested to have NTE-related esterase activity [40, 41], whereas a more recent study  showed that PNPLA7 is a lysophospholipase.
In silico characterization
The avian proteins (except PNPLA3, due to the incomplete sequence information) were analyzed using in silico methods to characterize their properties in more detail. PNPLA2/ATGL contains a predicted nuclear localization signal (VKKAKKKL) at residues 382–389 (the corresponding sequence in human PNPLA2, VMRAKRKL, is not predicted as nuclear localization signal) PNPLA1, -6, -7, -8, and -9 have one or more predicted tyrosine kinase phosphorylation sites. Both PNPLA6 and PNPLA7 contain two putative cyclic nucleotide binding sites indicating that they may be regulated by either cAMP or cGMP. Similar to its human orthologue, chicken PNPLA9 contains several ankyrin repeats, suggesting the potential for protein-protein interactions. The structures of CGI-58 and of all PNPLAs except PNPLA8 are predicted to be globular. Of the fully cloned PNPLAs (PNPLA2/ATGL, PNPLA4, -7, -8, and -9), only PNPLA4 is predicted to contain a signal peptide. PNPLAs 4 and -7 are predicted to contain transmembrane domains at residues 7–26 and 31–53, respectively. Human PNPLA6 was not predicted to contain a membrane spanning domain, but biochemical evidence suggests that its catalytic domain is associated with membranes in neurons . Based on the almost complete identity of the core module sequence to that of human PNPLA6 (Figure 4), this may also be the case for the chicken enzyme. N-glycosylation sites are found in each of the proteins; within both PNPLA2/ATGL and PNPLA4, one N-glycosylation site is located at the N-terminal boundary of the patatin domain, and in PNPLA9 it is close to the C-terminal boundary, respectively.
This is the first study providing insights into the avian patatin domain-containing family of proteins whose mammalian orthologs are known to be lipases that act in several critical physiological processes. The significant degree of sequence conservation for the proposed PNPLAs and CGI-58 proteins in chicken to those of known human proteins lends strong support to the notion that these proteins play critical roles in avian lipid biology. While the catalytic mechanism of most lipases proceeds through the nucleophilic attack of a serine-histidine-aspartate triad  and is reminiscent of serine proteases, the patatin family of enzymes operates via a serine-aspartate dyad. The serine of this dyad is located in a so-called nucleophilic elbow, which itself is part of a region suggested by Schneider et al.  to represent an ancestral sequence module, i.e., one found in both the patatin family (harboring a catalytic dyad) and other lipases, general esterases, and (lyso)phospholipases (operating via a triad). This sequence module, consisting of 50–70 residues forming the β-2 - β-1 - α+1 - β+1 core (Figure 4), is sometimes interrupted by inserts that may have arisen during evolution . The characteristic nucleophilic elbow of general esterases is located in the loop between the end of the second β-strand and the start of the α-helix. As shown in Figure 4, the overall structure of the ancestral module clearly is present in the chicken's patatin-like lipases, and the insert lengths are identical between the human and chicken homologue in each of the seven members for which this information could be obtained. Importantly, the active site residues are highly conserved. In addition, in the primary sequence they are flanked by hydrophilic regions.
As revealed by crystal structural analysis, the active site serine-aspartate dyad of the plant patatin  and human cytosolic phospholipase A2 is located in a deep cleft at the bottom of a funnel . The surface of this funnel is predominantly hydrophobic so as to allow access of fatty acid moieties of substrates. The two glycines in the lipase motif (GXSXG) are structurally essential for the tight turn of the nucleophilic elbow.
As in the murine protein, the protein predicted for the chicken PNPLA2/ATGL contains a potential lipid binding site at residues 311–395 . Importantly, this lipid binding site, unlike other portions of the protein, is as highly conserved as the patatin-like domain. A putative nuclear localization signal (NLS) (predicted at residues 382–389 in the avian sequence) is absent from the human protein, however, and none of the other known PNPLAs are predicted to harbor any NLS; thus, the significance of this observation remains unclear. In man, deficiency of PNPLA2/ATGL causes neutral lipid storage disease with myopathy (OMIM 610717) . Genetic variations within the human PNPLA2/ATGL gene influence fasting free fatty acid and glucose levels as well as the risk to develop type 2 diabetes . To date, five mutations in human PNPLA2/ATGL have been reported that cause neutral lipid storage disease with myopathy. One is a mutation in which a tetranucleotide duplication leads to a premature truncation of the patatin domain . Fischer et al.  reported three patients with milder phenotypes, and described four mutant alleles. Three of the mutations are predicted to lead to truncated PNPLA2/ATGL proteins with intact patatin domains, and the fourth leads to a single amino acid substitution (P195L). The affected proline is conserved in human PNPLAs 1–5 and also in chicken PNPLAs 1–4, further indicating an important structural role of the residue.
CGI-58, an activator of PNPLA2/ATGL, belongs to the esterase/thioesterase/lipase subfamily of proteins which are structurally characterized by the presence of α/β-hydrolase folds. Its interaction with PNPLA2/ATGL is required for TG hydrolysis . An intrinsic lipolytic activity of CGI-58 could not be demonstrated to date ; however, CGI-58 may couple lipolytic degradation of cytoplasmic TG to oxidation and packaging into TG-rich lipoproteins for secretion in hepatoma cells . CGI-58 reversibly binds to lipid droplets via perilipin A in the basal state [48, 49], whereas PNPLA2/ATGL does not interact with perilipin A . During hormone-stimulated lipolysis, perilipin A phosphorylation by protein kinase A rapidly decreases the interaction between CGI-58 and perilipin A; thus, perilipin A indirectly controls PNPLA2/ATGL activity . The important role of CGI-58 in lipase activation is further underscored by the fact that deficiency of CGI-58 in man [23, 24] leads to Chanarin-Dorfman syndrome, characterized by the presence of abnormally large amounts of TG-rich lipid droplets in many tissues.
As in mammals, the predominant expression of chicken PNPLA2/ATGL and CGI-58 in adipose tissue is compatible with the high demand on TG-lipolysis in this tissue. In the chicken, certain tissues such as liver, brain, kidney, heart, skeletal muscle, and skin also show high PNPLA2/ATGL and CGI-58 mRNA abundances, largely in concordance with the sites of TG accumulation in PNPLA2/ATGL deficient patients . In addition, the yolk sac of the chicken embryo shows similarly high mRNA abundances of these genes as well as that of PNPLA7. These observations suggest key roles for the gene products in embryonic yolk mobilization and utilization. PNPLA2/ATGL has been shown to be the main target for activation by CGI-58 . Differences between PNPLA2/ATGL and CGI-58 expression levels may indicate that CGI-58 possibly activates other lipases as well; the mRNA expression level differences might not reflect the protein levels, however, as reported for e.g., subcutaneous and visceral adipose tissue of obese human subjects . In addition, Schweiger et al. suggested that mammalian PNPLA2/ATGL likely represents the only lipase activated by CGI-58 . In this context, chicken CGI-58 transcript levels are high in skeletal muscle, where PNPLA3, -7, and -8 also are highly expressed, whereas human PNPLA3 is reported to be expressed exclusively in adipose tissue .
The high levels of PNPLA6 and -9 in the brain and of PNPLA4 in testis, respectively, may indicate tissue specific role(s) of these enzymes. In this respect, PNPLA6 is inhibited by organophosphate compounds, leading to delayed neuropathy in man  and chicken . Indeed, adult hens are usually used as the animal model for experimental studies of organophosphate-induced delayed neuropathy (OPIDN). The human, murine, and galline PNPLA6s have been reported to hydrolyze a number of lysophospholipids [35–37]. Recently, Chang et al. reported partial cloning of the chicken PNPLA6 cDNA . These authors described a novel 3' cDNA sequence to which we add new 5' sequence information and confirm the remaining cDNA sequence reported by them. Human  and chicken PNPLA6 do not appear to operate through a conventional catalytic triad, as both proteins contain two aspartate residues, rather than a histidine residue, in addition to the nucleophilic serine. It is interesting to note that while PNPLA6 and -7 are a pair forming one patatin subfamily, and PNPLA8 and -9 form another (cf. Figure 4), expression levels of PNPLA6 and -9 are high in brain, and those of PNPLA7 and -8 in skeletal muscle. This may point to evolution of the two pairs towards performing non-redundant functions in different tissues. In heart, co-expression of PNPLAs 6–9 may indicate the particularly high and complex energy demand of different classes of myocytes.
Currently, we have no evidence that PNPLA5 exists in chicken. We failed to detect any DNA or protein sequence similar to the human or other known orthologs in the chicken sequence databases available. Likewise, we could not find any relevant ESTs in the available chicken EST-databases [27, 28]. Lake et al.  used qPCR to show that PNPLA5 mRNA abundance was greatest in lung, epididymal fat, and brown adipose tissue, but that these expression levels were also ~10000-fold lower than those of PNPLA2/ATGL or PNPLA3 in these same tissues, and undetectable by Northern-blotting . PNPLA5 was induced in the liver of ob/ob mice, indicating that the regulation of PNPLA5 resembles that of genes involved in hepatic lipogenesis rather than lipolysis . However, it was undetectable in livers of wild-type C57BI/6J mice, and the human ortholog was found almost exclusively in brain . In this context, the human PNPLA3, PNPLA5 and PNPLA9 loci are syntenic on human chromosome 22q13, and the galline PNPLA3 and PNPLA9 loci on chromosome 1. Further studies are required to clarify whether galline PNPLA5 is syntenic with PNPLA3 and PNPLA9, but lies in a region with lacking sequence information, or is in fact absent from the entire chicken genome. Finally, our results on galline PNPLA1 are in line with the results obtained with PNPLA1 from man  and mouse  in that only partial cDNA sequence could be obtained, and attempts to generate qPCR products, even with several sets of primers, failed. Taken together, the available data suggest that PNPLA1 may not be expressed at detectable levels in any of the three species.
Overall, we note that the expression patterns of several members of the patatin-like lipase family vary significantly in the different species studied to date. For instance, PNPLA3 mRNA levels are high in foetal and adult human liver , but not in murine liver (Figure 2B in ), and is predicted to be high in chicken skeletal muscle (Figure 6), a tissue which in the mouse does not express the enzyme . PNPLA4 shows considerable expression in human heart and skeletal muscle , whereas its expression is moderate in chicken heart and skeletal muscle and greatest in the testis (Figure 6). Furthermore, PNPLA5 expression is high in human brain , but not in murine brain , whereas expression is high in the lung of mice , but not of man . On the other hand, a notable exception to these examples is PNPLA2/ATGL, whose expression in adipose tissue consistently prevails over that in other tissues in all species. Since preliminary results (J. Schatte and A. Hermetter, personal communication) indicate that chicken PNPLA2/ATGL indeed possesses TG-lipase activity that is enhanced by CGI-58, it is likely that also the other PNPLA genes have important in-vivo roles in the chicken. Another tissue with significant expression of PNPLA2/ATGL (and of PNPLA7) is the yolk sac of the avian embryo, where lipases likely have significant functions in the mobilization of lipid components from yolk for utilization by the embryo. In this context, Kienesberger et al.  have provided strong evidence that murine PNPLA7 is a lysophospholipase that is regulated by nutritional status and insulin.
Major transformations in yolk lipid composition occur during the transport across the yolk sac, an extraembryonic structure consisting of an outer mesoderm of flattened support cells and an inner layer of endodermal endothelial cells (EECs). The EECs are responsible for yolk absorption and secretion of de novo synthesized lipids and lipoproteins into capillaries emanating from villi on the basal surface of the EECs . Thus, the chick embryo's yolk sac functions in lipid transport highly analogous to the mammalian placenta in terms of nutrient provision to the embryo, and/or to the processes of intestinal lipid absorption and secretion. Following uptake of lipids into the yolk sac, almost all unesterified yolk cholesterol (80% of total cholesterol) is esterified, which then amounts to 81% of the total cholesterol in the yolk sac. One striking observation associated with lipid metabolism in the avian embryo is that the proportions of 20:4n-6 and 22:6n-3 fatty acids progressively increase during transit from yolk to the embryonic plasma. Lipolytic and re-esterification processes involving lipases lead to the almost exclusive presence of 22:6n-3 fatty acid in the phospholipid fraction of yolk, but interestingly, 22:6n-3 is subsequently present in the embryonic plasma's TG-rich lipoproteins, which originate in the EECs. There is an almost 60-fold enrichment of 22:6n-3 from yolk TG to plasma TG ; 20:4n-6 preferentially distributes to phospholipids in yolk and embryonic plasma, with much smaller changes in concentrations between the fractions than observed for 22:6n-3. These and other observations  are compatible with the involvement of multiple hydrolytic activities in cholesterol esterification, desaturation/elongation reactions, translocation of 22:6n-3 from phospholipids to TG, and in the overall conversion of yolk lipid components to plasma lipoproteins that supply the developing embryonic organs via specific uptake mechanisms.
Future studies will address the detailed temporal expression patterns of the patatin-like putative lipases identified, and of other already known extracellular lipases and co-factors, in the yolk sac and the embryonic tissues during embryonic development. Knowledge about the exact in-vivo functions of these enzymes in any system is still sparse. Based on the information gained here, it is reasonable to anticipate important insights of general relevance through exploitation of the advantages of the chick system [55, 56].
Data mining of the draft genome of Gallus gallus combined with cDNA cloning and tissue expression analysis by quantitative PCR have resulted in the first identification of hitherto unknown putative lipolytic enzymes in this powerful experimental system. Comparison of findings in birds, which split from the mammalian lineage about 310 million years ago, with those in mammals provides additional analytical power. This fact is demonstrated here for the gene family encoding patatin domain-containing proteins which putatively function as lipases. Future studies in the chicken may reveal important features shared by this gene family and their products in different animal phyla.
Animals and tissue samples
Derco white laying hens (30–40 weeks old) and roosters were purchased from Heindl Co. (Vienna, Austria) and maintained on layer's mash with free access to water and feed under a daily light period of 14 h. Fertilized chicken eggs were incubated under standard conditions for temperature (38°C) and humidity (70%). The eggs were removed from the incubator after 11 days of incubation, and the shell was cut to expose the yolk sac membrane. The yolk sac membranes were excised and washed with ice-cold phosphate-buffered saline (PBS) and subsequently used for RNA extraction as described below. The preovulatory small white (less than 5-mm diameter, without yolk) and small yellow follicles (5–12-mm diameter, with yolk) form a pool from which the hierarchical follicles (F1-F7) develop. The F1 follicle is the largest and most mature follicle (to be ovulated on collection day), while higher numbered follicles are progressively smaller and less mature. Granulosa cells were isolated from F5 – F1 follicles and washed with PBS . Other chicken tissue samples were immediately frozen in liquid nitrogen after collection of samples or used for RNA extraction. White adipose tissue was obtained from the abdominal cavity.
Total RNA extraction, cDNA synthesis, and sequencing
Primers used for the cloning of chicken cDNAs.
Melting temperature (°C)
Nucleotide sequence accession numbers
The mRNA sequences of the chicken PNPLAs and CGI-58 were deposited in GenBank under accession numbers: EU419873 for CGI-58, EU419874 for PNPLA2/ATGL, EU419875 for PNPLA3, EU419876 for PNPLA1, EU419877 for PNPLA4, EU419878 for PNPLA8, EU419879 for PNPLA9, EU419880 for PNPLA6, and EU419881 for PNPLA7.
Quantitative real time PCR
Primers used for the qPCR analyses.
Melting temperature (°C); Temperature of fluorescence measurement (°C)
In silico characterization
The obtained sequences were analyzed using the PredictProtein , and SignalP . Multiple sequence alignment and phylogenetic tree calculation were performed using ClustalW2 . Transmembrane helices were predicted using TMHMM 2.0 .
Calcium-independent phospholipase A2
Quantitative real time PCR
Comparative gene identification 58
very low density lipoprotein
adiposome triglyceride lipase
endodermal endothelial cell.
We are grateful to Dr. Zlatko Trajanoski, University of Graz and Dr. Hubert Hackl for help with data presentation, and to Astrid Pentz, B.Sc., for technical assistance. These studies were supported by the grant "GOLDII -Genomics of Lipid-Associated Disorders-II", which is part of the Austrian Genome Project "GEN-AU Genome Research in Austria" and is funded by the Austrian Ministry for Education, Research, and Culture, and by a grant from The Austrian Research Foundation (FWF P20218). JS was in part supported by Fellowship grants from the Academy of Finland (Nr 209723 and Nr 114687).
- Walzem RL: Lipoproteins and the laying hen: form follows function. Poult Avian Biol Rev. 1996, 7: 31-64.Google Scholar
- Schneider WJ, Osanger A, Waclawek M, Nimpf J: Oocyte growth in the chicken: receptors and more. Biol Chem. 1998, 379: 965-971.PubMedGoogle Scholar
- Bergink EW, Wallace RA: Estrogen-induced synthesis of yolk proteins in roosters. Am Zool. 1974, 14: 1177-1193.View ArticleGoogle Scholar
- Kirchgessner TG, Heinzmann C, Svenson KL, Gordon DA, Nicosia M, Lebherz HG, Lusis AJ, Williams DL: Regulation of chicken apolipoprotein B: cloning, tissue distribution, and estrogen induction of mRNA. Gene. 1987, 59: 241-251. 10.1016/0378-1119(87)90332-5.PubMedView ArticleGoogle Scholar
- Speake BK, Murray AM, Noble RC: Transport and transformations of yolk lipids during development of the avian embryo. Prog Lipid Res. 1998, 37: 1-32. 10.1016/S0163-7827(97)00012-X.PubMedView ArticleGoogle Scholar
- Schneider WJ, Carroll R, Severson DL, Nimpf J: Apolipoprotein VLDL-II inhibits lipolysis of triglyceride-rich lipoproteins in the laying hen. J Lipid Res. 1990, 31: 507-513.PubMedGoogle Scholar
- Hermann M, Mahon MG, Lindstedt KA, Nimpf J, Schneider WJ: Lipoprotein receptors in extraembryonic tissues of the chicken. J Biol Chem. 2000, 275: 16837-16844. 10.1074/jbc.M000163200.PubMedView ArticleGoogle Scholar
- Griffin H, Grant G, Perry M: Hydrolysis of plasma triacylglycerol-rich lipoproteins from immature and laying hens (Gallus domesticus) by lipoprotein lipase in vitro. Biochem J. 1982, 206: 647-654.PubMedPubMed CentralView ArticleGoogle Scholar
- Bacon WL, Leclercq B, Blum JC: Difference in metabolism of very low density lipoprotein from laying chicken hens in comparison to immature chicken hens. Poult Sci. 1978, 57: 1675-1686.PubMedView ArticleGoogle Scholar
- Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW: Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem. 2004, 279: 48968-48975. 10.1074/jbc.M407841200.PubMedView ArticleGoogle Scholar
- Lake AC, Sun Y, Li JL, Kim JE, Johnson JW, Li D, Revett T, Shih HH, Liu W, Paulsen JE, Gimeno RE: Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J Lipid Res. 2005, 46: 2477-2487. 10.1194/jlr.M500290-JLR200.PubMedView ArticleGoogle Scholar
- Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R: Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004, 306: 1383-1386. 10.1126/science.1100747.PubMedView ArticleGoogle Scholar
- Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006, 312: 734-737. 10.1126/science.1123965.PubMedView ArticleGoogle Scholar
- Vancanneyt G, Sonnewald U, Hofgen R, Willmitzer L: Expression of a Patatin-like Protein in the Anthers of Potato and Sweet Pepper Flowers. Plant Cell. 1989, 1: 533-540. 10.1105/tpc.1.5.533.PubMedPubMed CentralView ArticleGoogle Scholar
- PFAM, family: patatin (PF01734). [http://pfam.sanger.ac.uk/family?entry=PF01734&type=Family]
- Rydel TJ, Williams JM, Krieger E, Moshiri F, Stallings WC, Brown SM, Pershing JC, Purcell JP, Alibhai MF: The crystal structure, mutagenesis, and activity studies reveal that patatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad. Biochemistry. 2003, 42: 6696-6708. 10.1021/bi027156r.PubMedView ArticleGoogle Scholar
- Schneider G, Neuberger G, Wildpaner M, Tian S, Berezovsky I, Eisenhaber F: Application of a sensitive collection heuristic for very large protein families: evolutionary relationship between adipose triglyceride lipase (ATGL) and classic mammalian lipases. BMC Bioinformatics. 2006, 7: 164-10.1186/1471-2105-7-164.PubMedPubMed CentralView ArticleGoogle Scholar
- Dessen A, Tang J, Schmidt H, Stahl M, Clark JD, Seehra J, Somers WS: Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell. 1999, 97: 349-360. 10.1016/S0092-8674(00)80744-8.PubMedView ArticleGoogle Scholar
- Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ: Characterization of the human patatin-like phospholipase family. J Lipid Res. 2006, 47: 1940-1949. 10.1194/jlr.M600185-JLR200.PubMedView ArticleGoogle Scholar
- Kurat CF, Natter K, Petschnigg J, Wolinski H, Scheuringer K, Scholz H, Zimmermann R, Leber R, Zechner R, Kohlwein SD: Obese yeast: triglyceride lipolysis is functionally conserved from mammals to yeast. J Biol Chem. 2006, 281: 491-500. 10.1074/jbc.M508414200.PubMedView ArticleGoogle Scholar
- Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS: Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem. 2004, 279: 47066-47075. 10.1074/jbc.M403855200.PubMedView ArticleGoogle Scholar
- Lass A, Zimmermann R, Haemmerle G, Riederer M, Schoiswohl G, Schweiger M, Kienesberger P, Strauss JG, Gorkiewicz G, Zechner R: Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab. 2006, 3: 309-319. 10.1016/j.cmet.2006.03.005.PubMedView ArticleGoogle Scholar
- Lefevre C, Jobard F, Caux F, Bouadjar B, Karaduman A, Heilig R, Lakhdar H, Wollenberg A, Verret JL, Weissenbach J, Ozguc M, Lathrop M, Prud'homme JF, Fischer J: Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet. 2001, 69: 1002-1012. 10.1086/324121.PubMedPubMed CentralView ArticleGoogle Scholar
- Ben Selma Z, Yilmaz S, Schischmanoff PO, Blom A, Ozogul C, Laroche L, Caux F: A novel S115G mutation of CGI-58 in a Turkish patient with Dorfman-Chanarin syndrome. J Invest Dermatol. 2007, 127: 2273-2276. 10.1038/sj.jid.5700860.PubMedView ArticleGoogle Scholar
- Liu YM, Moldes M, Bastard JP, Bruckert E, Viguerie N, Hainque B, Basdevant A, Langin D, Pairault J, Clement K: Adiponutrin: A new gene regulated by energy balance in human adipose tissue. J Clin Endocrinol Metab. 2004, 89: 2684-2689. 10.1210/jc.2003-031978.PubMedView ArticleGoogle Scholar
- Baulande S, Lasnier F, Lucas M, Pairault J: Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem. 2001, 276: 33336-33344. 10.1074/jbc.M105193200.PubMedView ArticleGoogle Scholar
- BBSRC ChickEST Database. [http://www.chick.manchester.ac.uk/]
- University of Delaware Chick EST Database. [http://www.chickest.udel.edu/]
- Tang J, Kriz RW, Wolfman N, Shaffer M, Seehra J, Jones SS: A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J Biol Chem. 1997, 272: 8567-8575. 10.1074/jbc.272.13.8567.PubMedView ArticleGoogle Scholar
- Bertoncin D, Russolo A, Caroldi S, Lotti M: Neuropathy target esterase in human lymphocytes. Arch Environ Health. 1985, 40: 139-144.PubMedView ArticleGoogle Scholar
- Johnson MK: Organophosphorus and other inhibitors of brain 'neurotoxic esterase' and the development of delayed neurotoxicity in hens. Biochem J. 1970, 120: 523-531.PubMedPubMed CentralView ArticleGoogle Scholar
- van Tienhoven M, Atkins J, Li Y, Glynn P: Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J Biol Chem. 2002, 277: 20942-20948. 10.1074/jbc.M200330200.PubMedView ArticleGoogle Scholar
- Zaccheo O, Dinsdale D, Meacock PA, Glynn P: Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Biol Chem. 2004, 279: 24024-24033. 10.1074/jbc.M400830200.PubMedView ArticleGoogle Scholar
- Glynn P: Neuropathy target esterase. Biochem J. 1999, 344 (Pt 3): 625-631. 10.1042/0264-6021:3440625.PubMedPubMed CentralView ArticleGoogle Scholar
- Wang A, Yang HC, Friedman P, Johnson CA, Dennis EA: A specific human lysophospholipase: cDNA cloning, tissue distribution and kinetic characterization. Biochim Biophys Acta. 1999, 1437: 157-169.PubMedView ArticleGoogle Scholar
- Winrow CJ, Hemming ML, Allen DM, Quistad GB, Casida JE, Barlow C: Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat Genet. 2003, 33: 477-485. 10.1038/ng1131.PubMedView ArticleGoogle Scholar
- Quistad GB, Barlow C, Winrow CJ, Sparks SE, Casida JE: Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc Natl Acad Sci USA. 2003, 100: 7983-7987. 10.1073/pnas.1232473100.PubMedPubMed CentralView ArticleGoogle Scholar
- Smith MI, Elvove E, Frazier WH: The pharmacological action of certain phenol esters, with special reference to the etiology of so-called ginger paralysis. Public Health Rep. 1930, 45: 2509-2524.View ArticleGoogle Scholar
- Kienesberger PC, Lass A, Preiss-Landl K, Wolinski H, Kohlwein SD, Zimmermann R, Zechner R: Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase. J Biol Chem. 2007Google Scholar
- Xie M, Yang D, Matoney L, Yan B: Rat NTE-related esterase is a membrane-associated protein, hydrolyzes phenyl valerate, and interacts with diisopropylfluorophosphate through a serine catalytic machinery. Arch Biochem Biophys. 2003, 416: 137-146. 10.1016/S0003-9861(03)00264-9.PubMedView ArticleGoogle Scholar
- Chang PA, Long DX, Wu YJ: Molecular cloning and expression of the C-terminal domain of mouse NTE-related esterase. Mol Cell Biochem. 2007, 306: 25-32. 10.1007/s11010-007-9550-2.PubMedView ArticleGoogle Scholar
- Atkins J, Glynn P: Membrane association of and critical residues in the catalytic domain of human neuropathy target esterase. J Biol Chem. 2000, 275: 24477-24483. 10.1074/jbc.M002921200.PubMedView ArticleGoogle Scholar
- Zechner R, Strauss JG, Haemmerle G, Lass A, Zimmermann R: Lipolysis: pathway under construction. Curr Opin Lipidol. 2005, 16: 333-340. 10.1097/01.mol.0000169354.20395.1c.PubMedView ArticleGoogle Scholar
- Fischer J, Lefevre C, Morava E, Mussini JM, Laforet P, Negre-Salvayre A, Lathrop M, Salvayre R: The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet. 2007, 39: 28-30. 10.1038/ng1951.PubMedView ArticleGoogle Scholar
- Schoenborn V, Heid IM, Vollmert C, Lingenhel A, Adams TD, Hopkins PN, Illig T, Zimmermann R, Zechner R, Hunt SC, Kronenberg F: The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes. Diabetes. 2006, 55: 1270-1275. 10.2337/db05-1498.PubMedView ArticleGoogle Scholar
- Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H: Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve. 2007, 36: 856-859. 10.1002/mus.20869.PubMedView ArticleGoogle Scholar
- Brown JM, Chung S, Das A, Shelness GS, Rudel LL, Yu L: CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cells. J Lipid Res. 2007, 48: 2295-2305. 10.1194/jlr.M700279-JLR200.PubMedView ArticleGoogle Scholar
- Yamaguchi T, Omatsu N, Matsushita S, Osumi T: CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J Biol Chem. 2004, 279: 30490-30497. 10.1074/jbc.M403920200.PubMedView ArticleGoogle Scholar
- Subramanian V, Rothenberg A, Gomez C, Cohen AW, Garcia A, Bhattacharyya S, Shapiro L, Dolios G, Wang R, Lisanti MP, Brasaemle DL: Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem. 2004, 279: 42062-42071. 10.1074/jbc.M407462200.PubMedView ArticleGoogle Scholar
- Granneman JG, Moore HP, Granneman RL, Greenberg AS, Obin MS, Zhu Z: Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem. 2007, 282: 5726-5735. 10.1074/jbc.M610580200.PubMedView ArticleGoogle Scholar
- Steinberg GR, Kemp BE, Watt MJ: Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab. 2007, 293: E958-964. 10.1152/ajpendo.00235.2007.PubMedView ArticleGoogle Scholar
- Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R: Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem. 2006, 281: 40236-40241. 10.1074/jbc.M608048200.PubMedView ArticleGoogle Scholar
- Chang P-A, Long D-X, Wu Y-J: Molecular cloning and expression of chicken neuropathy target esterase activity domain. Toxicol Lett. 2007, 174: 42-48. 10.1016/j.toxlet.2007.08.011.PubMedView ArticleGoogle Scholar
- Maldjian A, Farkas K, Noble RC, Cocchi M, Speake BK: The transfer of docosahexaenoic acid from the yolk to the tissues of the chick embryo. Biochim Biophys Acta. 1995, 1258: 81-89.PubMedView ArticleGoogle Scholar
- Stern CD: The chick; a great model system becomes even greater. Dev Cell. 2005, 8: 9-17.PubMedGoogle Scholar
- Rallis C: Chickens get their place in the sun. Genome Biol. 2007, 8: 306-10.1186/gb-2007-8-5-306.PubMedPubMed CentralView ArticleGoogle Scholar
- Hummel S, Christian S, Osanger A, Heid H, Nimpf J, Schneider WJ: Identification of a novel chondroitin-sulfated collagen in the membrane separating theca and granulosa cells in chicken ovarian follicles: the granulosa-theca cell interface is not a bona fide basement membrane. J Biol Chem. 2007, 282: 8011-8018. 10.1074/jbc.M606029200.PubMedView ArticleGoogle Scholar
- Ensembl Chicken (assembly: WASHUC2, May 2006). [http://www.ensembl.org/Gallus_gallus/index.html]
- PredictProtein. [http://www.predictprotein.org/]
- SignalP 3.0. [http://www.cbs.dtu.dk/services/SignalP]
- ClustalW2. [http://www.ebi.ac.uk/Tools/clustalw2/index.html]
- TMHMM 2.0. [http://www.cbs.dtu.dk/services/TMHMM-2.0/]
- Sturn A, Quackenbush J, Trajanoski Z: Genesis: cluster analysis of microarray data. Bioinformatics. 2002, 18: 207-208. 10.1093/bioinformatics/18.1.207.PubMedView ArticleGoogle Scholar
- GenBank. [http://www.ncbi.nlm.nih.gov/Genbank/]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.